tiprankstipranks
Advertisement
Advertisement

Rockwell Medical Faces Nasdaq Compliance Challenge, Eyes Reverse Split

Story Highlights
  • On May 8, 2026, Rockwell Medical disclosed a Nasdaq notice over its sub-$1 share price.
  • Rockwell plans a potential reverse stock split to regain Nasdaq compliance and protect its listing.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Rockwell Medical Faces Nasdaq Compliance Challenge, Eyes Reverse Split

Meet Samuel – Your Personal Investing Prophet

Rockwell Med ( (RMTI) ) just unveiled an update.

On May 8, 2026, Rockwell Medical, Inc. disclosed that it had received a notice from Nasdaq stating the company was no longer in compliance with the exchange’s $1.00 minimum bid price requirement, after its shares traded below that threshold for 30 consecutive business days. The notice does not immediately affect the stock’s listing, and Rockwell has until November 4, 2026, to regain compliance by having its closing bid price at or above $1.00 for at least ten consecutive business days.

The company has proposed a reverse stock split in its 2026 annual meeting proxy, a move it believes would restore compliance with Nasdaq’s listing rules if approved and implemented. Failure to regain compliance by the deadline could jeopardize Rockwell’s Nasdaq listing, though the company may qualify for additional time, leaving shareholders attentive to both the stock’s performance and the outcome of the reverse split proposal.

The most recent analyst rating on (RMTI) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Rockwell Med stock, see the RMTI Stock Forecast page.

Spark’s Take on RMTI Stock

According to Spark, TipRanks’ AI Analyst, RMTI is a Neutral.

The score reflects a strong balance sheet and constructive 2026 guidance (margin expansion, expected positive operating cash flow) offset by weak current profitability/cash-flow consistency and bearish technical signals with the stock trading below major moving averages.

To see Spark’s full report on RMTI stock, click here.

More about Rockwell Med

Rockwell Medical, Inc. operates in the healthcare sector and is listed on the Nasdaq Capital Market. The company’s common stock is subject to Nasdaq’s continued listing standards, including minimum bid price requirements that govern ongoing eligibility for trading on the exchange.

Average Trading Volume: 260,530

Technical Sentiment Signal: Sell

Current Market Cap: $30.78M

See more data about RMTI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1